Category: Multiple Sclerosis Research

New MS research finds early immune activity in myelin cells

Posted on by

Oligodendrocytes, the cells that build and repair myelin in the brain and spinal cord, may play a role in the inflammatory processes involved in multiple sclerosis (MS), even at the earliest stages of disease, according to a study in a mouse model. “We found that oligodendrocytes transition to disease states already at early stages in…

+

Lower-dose contrast agent Vueway passes 3M doses

Posted on by

More than 3 million doses of Vueway (gadopiclenol), a lower-dose gadolinium contrast MRI agent used to diagnose and monitor conditions such as multiple sclerosis (MS), have been administered at more than 900 customer sites, maker Bracco Diagnostics said. Approved by the U.S. Food and Drug Administration for use in children and adults, ages 2 years and older,…

+

At the holidays, MS turns sensory input into neurological overload

Posted on by

The holidays have a way of turning up the volume on everything. The lights feel brighter, rooms feel busier, and even soft conversation seems amplified. Living with multiple sclerosis (MS) has taught me that this kind of noise isn’t just sound — it’s work. It’s one of the reasons my Thanksgiving table has grown smaller…

+

Two-protein blood test may better track MS activity, disability

Posted on by

Simultaneously measuring levels of two blood proteins — glial fibrillary acidic protein (GFAP) and neurofilament light chain (NfL) — may offer a clearer way to track both disease activity and disability progression in people with multiple sclerosis (MS), according to a new long-term study. Each marker is tied to a different clinical outcome: NfL helps…

+